Home / Events

U.S. & Israeli Innovations in the Life Science: Part 2

When: March 2, 2021 12:00 PM to 1:00 PM
Where: Miami, FL
Organizer:
Contact: Mike Teichberg at [email protected] ((305) 682-0025 x897)
Summary: Join attorneys, scientists, investors, entrepreneurs, and the Jewish National Fund community for an exclusive panel discussion with industry experts from the BioTech and Pharmaceutical sectors of Israel and Miami.
More information
2021-03-02 12:00:00 2021-03-02 13:00:00 America/New_York U.S. & Israeli Innovations in the Life Science: Part 2 Join attorneys, scientists, investors, entrepreneurs, and the Jewish National Fund community for an exclusive panel discussion with industry experts from the BioTech and Pharmaceutical sectors of Israel and Miami. (http://jewishmiami.org/events/us_israeli_innovations_in_the_life_science_part_2) Miami,FL [email protected]

Event Details

Description

Join attorneys, scientists, investors, entrepreneurs, and the Jewish National Fund community for an exclusive panel discussion with industry experts from the BioTech and Pharmaceutical sectors of Israel and Miami.

Hear about the potential COVID-19 “cure” Allocetra developed by Enlivex Therapeutics from Chief Scientific & Medical Officer Dror Mevorach during an intimate fireside chat.

The program will also include a lively discussion with a Miami & Israeli BioTech Panel featuring Isaac Litman, Founder & CEO of Neteera Technologies, Dr. Osnat Sela Tavor, CTO of Nanose Medical, and Andrew Satz, CEO of EVQLV, moderated by Meital Stavinsky, Partner at Holland & Knight. As part of the day’s program, learn about Jewish National Fund’s latest food technology endeavor from Nathan Hoffman, CEO of the upcoming Galilee Culinary Institute by JNF.

Moderator
Meital Stavinsky

Partner, Holland & Knight

Co-Chair of Israel Practice

Fireside Chat on COVID-19 Cure
Professor Dror Mevorach

Chief Scientific and Medical Officer, Enlivex Therapeutics

Director Rheumatology Research Center & Chairman of Medicine, Hadassah Medical Center in Jerusalem

Miami/Israel BioTech Panel
Isaac Litman

Founder & CEO, Neteera
Dr. Osnat Sela Tavor

CTO, Nanose Medical
Andrew Satz

CEO, EVQLV

Jewish National Fund Food Tech Update: Nathan Hoffman

CEO, Galilee Culinary Institute by JNF

Thank You To Our Sponsor
Gold Sponsor

Mr. Ronald Gerstl

Author of The Super Achievers: The Remarkable Jewish Contribution to Science and Human Well-being Highlighted by Nobel Prize Winners

Address

Miami, FL

U.S. & Israeli Innovations in the Life Science: Part 2

Actions

  • 2021-03-02 12:00:00 2021-03-02 13:00:00 America/New_York U.S. & Israeli Innovations in the Life Science: Part 2 Join attorneys, scientists, investors, entrepreneurs, and the Jewish National Fund community for an exclusive panel discussion with industry experts from the BioTech and Pharmaceutical sectors of Israel and Miami. (http://jewishmiami.org/events/us_israeli_innovations_in_the_life_science_part_2) Miami, FL [email protected]
  • Add New Event
Miami Jewish Community Study

Miami Jewish Community Study

In order to better understand the demographics and needs of Miami’s Jewish population, the Greater Miami Jewish Federation has launched its “Miami Jewish Community Study.”

Read More

Mental Health After 10/7

Mental Health After 10/7

Through donations to the Annual Greater Miami Jewish Federation/UJA Campaign and the Israel Emergency Fund, individuals coping with the gravity of October 7 are receiving support to begin the long healing journey ahead.

Read More

Make Your Federation Donation Tax-Deductible

Make Your Federation Donation Tax-Deductible

Nancy and Norman Lipoff pay their Annual Federation/UJA Campaign contributions through an IRA Charitable Rollover.

Read More

Join Your Community for Matzah Mitzvah


Join Your Community for Matzah Mitzvah


Help share the joy of Passover with Holocaust Survivors and other older adults in our community by participating in Matzah Mitzvah on Sunday, April 7 at 9 a.m.

Read More

Stay in Touch

Receive news about Greater Miami Jewish Federation events and more.